Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Insular cortex subregions have distinct roles in cued heroin seeking after extinction learning and prolonged withdrawal in rats
    Published on 2024-03-17
    2 years ago
  • Dnmt3a1 regulates hippocampus-dependent memory via the downstream target Nrp1
    Published on 2024-03-17
    2 years ago
  • Does steroid increase LPS-induced sickness behaviors?
    Published on 2024-03-14
    2 years ago
  • IN MEMORIAM—Brian E. Leonard PhD DSc MRIA
    Published on 2024-03-13
    2 years ago
  • Brain-based graph-theoretical predictive modeling to map the trajectory of anhedonia, impulsivity, and hypomania from the human functional connectome
    Published on 2024-03-12
    2 years ago
  • Lifespan development of thalamic nuclei and characterizing thalamic nuclei abnormalities in schizophrenia using normative modeling
    Published on 2024-03-12
    2 years ago
  • Elevated dorsal medial prefrontal cortex to lateral habenula pathway activity mediates chronic stress-induced depressive and anxiety-like behaviors
    Published on 2024-03-12
    2 years ago
« Previous 1 … 85 86 87 88 89 … 143 Next »
Journal of Psychopharmacology
  • Enhancement of the GluN2B subunit of glutamatergic NMDA receptors in rat brain areas after cocaine abstinence
    Published on 2021-09-30
    5 years ago
  • Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis
    Published on 2021-09-14
    5 years ago
  • Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour
    Published on 2021-09-14
    5 years ago
  • Three regulatory compliant test systems show no signs of MDMA-related genotoxicity
    Published on 2021-09-01
    5 years ago
  • Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group
    Published on 2021-08-04
    5 years ago
  • Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?
    Published on 2021-08-04
    5 years ago
  • Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials
    Published on 2021-07-31
    5 years ago
« Previous 1 … 85 86 87 88 89 … 145 Next »
European Neuropsychopharmacology
  • Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study
    Published on 2022-05-09
    4 years ago
  • Association between CACNA1C gene rs100737 polymorphism and glutamatergic neurometabolites in bipolar disorder
    Published on 2022-05-09
    4 years ago
  • Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications
    Published on 2022-04-15
    4 years ago
  • Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice?
    Published on 2022-04-07
    4 years ago
  • Mechanisms of action of anti-bipolar drugs
    Published on 2022-04-07
    4 years ago
  • Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA
    Published on 2022-04-02
    4 years ago
  • Is it time to change the term negative symptoms?
    Published on 2022-04-02
    4 years ago
« Previous 1 … 85 86 87 88 89 … 166 Next »

   Pharma Pub